Global Status of Genetically Modified Crops and Its Commercialization

This paper is relevant to the impact areas in the following areas:


Abstract or Summary

From last 20 years, commercialization of biotechnological crops confirms that the genetically modified crops have conveyed a significant agronomic, ecological, monetary, social, and health advantages to ranchers, and along this, it witnessed increased numbers of consumers. The regular appropriation of GM crops reflects the generous numerous advantages for both minor and large-scale ranchers in developed and in developing countries. The principle point of GM crops is to accomplish food security or to improve nutrition, enhance sustenance, and advance manageable farming. In 2016, from 26 countries, 19 are developing and 7 are industrial countries and these countries established a biotech crops but according to International Service for the Acquisition of Agri-biotech Applications (ISAAA) top ten countries including both developed (USA and Canada) and developing (Argentina, Brazil, China, India, Pakistan, Paraguay, South Africa, and Uruguay) countries which are growing biotech crops in 1.0 million hectors of land. Secondly, in 2016 biotech crops are globally increased from 179.7 million hectares to 185.1 million hectares, and an increase of 3% is equal to 5.4 million hectares. As per the study in 2015 global economic benefit 15.4 billion US$ (7.5 billion US$ was from developing and 7.9 billion US$ was from industrial countries).


Global Status of Genetically Modified Crops and Its Commercialization (held on an external server, and so may require additional authentication details)

CropLife International fully acknowledges the source and authors of the publication as detailed above.